US$ 21.16
depression glp 1 GLP-1 Agonists Can Be Heaven or Hell Dependent Upon Dopaminergic Genetic/Epigenetic Antecedents[v1] Study: Weight loss drug GLP-1
Description
No such trials have been announced
Mol Metab 6: 288294
![depression glp 1 GLP-1 Agonists Can Be Heaven or Hell Dependent Upon Dopaminergic Genetic/Epigenetic Antecedents[v1] Study: Weight loss drug GLP-1](https://www.frontiersin.org/files/Articles/560086/xml-images/fphar-11-01270-g001.webp)
Track Symptoms to Identify Fatigue Patterns Fatigue doesnt always show up at random
The retatrutide versus semaglutide comparison becomes even more dramatic when you consider these results came from a 48-week trial, not the 68-week trials used for semaglutide data
![depression glp 1 GLP-1 Agonists Can Be Heaven or Hell Dependent Upon Dopaminergic Genetic/Epigenetic Antecedents[v1] Study: Weight loss drug GLP-1](https://cdn.prod.website-files.com/67eb320892c08516077ad204/6911e545acb06a90f528edfb_rgeJLt5rF8gpNkyk9gEYulcLjSCV7XU-x7vLIP4QgK0.png)
38,39 The relationship between cardiac and renal dysfunction is critical for disease progression and prognosis
Exogenously imposed postprandial-like rises in systemic glucose and GLP-1 do not produce an incretin effect, suggesting an indirect mechanism of GLP-1 action
![depression glp 1 GLP-1 Agonists Can Be Heaven or Hell Dependent Upon Dopaminergic Genetic/Epigenetic Antecedents[v1] Study: Weight loss drug GLP-1](https://www.healio.com/~/media/slack-news/fm_im/misc/infographics/2024/09-september/pc0924wadden_graphic_01_web.jpg)